How the US, UK and China are planning to roll out vaccines

How the US, UK and China are planning to roll out vaccines

Many countries are making important decisions about who gets vaccinated and when—but the answers vary from nation to nation.

The vaccines are coming. The UK became the first country in the West to approve a covid-19 vaccine for emergency use on December 2, specifically the Pfizer and BioNTech vaccine, which has completed Phase 3 trials. But the US, EU, and many other countries are expected to follow suit in the following days and weeks. The imminent arrival of vaccines not only means that countries face a huge logistical challenge to distribute them—which is complicated by the fact the two most promising vaccines require ultra-cold temperatures—but they also have to grapple with hard choices over who gets them first. 

Here’s how different countries are making their decisions on distributing vaccines to their populations. 

United States

How many doses will be available? Up to 40 million doses are expected to be on offer in the US by the end of 2020—25 million of which will come from Pfizer-BioNTech, and 12.5 million from Moderna, according to Reuters. Since the vaccines each require two doses spaced several weeks apart, this will be enough to vaccinate 20 million people—but not all shipments will come at once. The first shipment will reportedly cover 3.2 million people, with 5-10 million more doses delivered each week after that.